Molecular characterization of the 17D-204 yellow fever vaccine (Q40141583)

17 September 2017

title

Molecular characterization of the 17D-204 yellow fever vaccine (English)

1 reference

17 September 2017

0 references

1 reference

8

1 reference

17 September 2017

Jerome LeGoff

7

0 references

author name string

Maud Salmona

1

1 reference

17 September 2017

Sandrine Gazaigne

2

1 reference

17 September 2017

Severine Mercier-Delarue

3

1 reference

17 September 2017

Fabienne Garnier

4

1 reference

17 September 2017

Jehanara Korimbocus

5

1 reference

17 September 2017

Nathalie Colin de Verdière

6

1 reference

17 September 2017

François Simon

9

1 reference

17 September 2017

language of work or name

English

0 references

publication date

24 August 2015

1 reference

17 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

17 September 2017

volume

33

1 reference

17 September 2017

issue

41

1 reference

17 September 2017

page(s)

5432-5436

1 reference

Review of the risks and benefits of yellow fever vaccination including some new analyses

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Yellow fever: a disease that has yet to be conquered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

THE TRANSMISSION OF YELLOW FEVER TO MACACUS RHESUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

The phylogeny of yellow fever virus 17D vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Flaviviruses and flavivirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Safety of 17D derived yellow fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

An inactivated cell-culture vaccine against yellow fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Dissection of antibody specificities induced by yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Phylogenetic and Evolutionary Relationships among Yellow Fever Virus Isolates in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.055

10.1016/J.VACCINE.2015.08.055

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference